Normal and Abnormal Puberty

Clinical Pediatric Endocrinology: Fifth Edition

Volumn , Issue , 2007, Pages 183-210

  Dattani, Mehul T ^a   Hindmarsh, Peter C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Delayed puberty; Gynecomastia; Physical changes; Puberty; Testicular development

Indexed keywords

EID: 84889473311     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987117.ch10     Document Type: Chapter

References (161)

1. Grumbach MM, Styne DM. Puberty, ontogeny, neuro-endocrinology, physiology, and disorders. In: Wilson JD, Foster DW, Kronenberg MD, Larsen PR, eds. Williams Textbook of Endocrinology, 9th edn. Philadelphia: WB Saunders, 1998: 1509-625.
2. Tanner JM. The trend toward earlier menarche in London, Oslo, Copenhagen, the Netherlands and Hungary. Nature 1973; 243: 95.
3. Parent A-S, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon J-P. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends and changes after migration. Endocr Rev 2003; 24: 668-93.
4. Evelith PB. Population differences in growth: environmental and genetic factors. In: Falkner F, Tanner JM, eds. Human Growth. New York: Plenum Press, 1979: 373-94.
5. Proos LA, Hofvander Y, Tuvemo T. Menarcheal age and growth pattern of Indian girls adopted in Sweden. I. Menarcheal age. Acta Paediatr Scand 1991; 80: 852-8.
6. Hartz AJ, Barboriak PN, Wong A. The association of obesity with infertility and related menstrual abnormalities in women. Int J Obes 1979; 3: 5773.
7. Osler DC, Crawford JD. Examination of the hypothesis of a critical weight at menarche in ambulatory and bedridden mentally retarded girls. Pediatrics 1973; 51: 674-9.
8. Takaishi, M. Secular changes in growth of Japanese children. J Pediatr Endocrinol 1994; 7: 163-73.
9. Mul D, Fredriks M, van Buuren S, Oosdijk W, Verloove-Vanhorick SP, Wit JM. Pubertal development in the Netherlands 1965-1997. Pediatr Res 2001; 50: 479-86.
10. de la Puente ML, Canela J, Alvarez J, Salleras L, Vicens-Calvet E. Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol 1997; 24: 435-52.
11. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
12. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23.
13. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc London B Biol Sci 1999; 158: 417-33.
14. Ross GT. Follicular development: the life cycle of the follicle and puberty. In: Grumbach MM, Sizonenko PC, Aubert MI, eds. Control of the Onset of Puberty. Baltimore: Williams & Wilkins, 1990: 376-86.
15. Stanhope R, Adams J, Jacobs HS et al. Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Arch Dis Child 1985; 60: 116-19.
16. Salardi S, Orsini LF, Cacciari E et al. Pelvic ultrasonography in girls with precocious puberty, congenital adrenal hyperplasia, obesity, or hirsutism. J Pediatr 1988; 112: 880-7.
17. Bridges NA, Cooke A, Healy MJ, Hindmarsh PC, Brook CG. Standards for ovarian volume in childhood and puberty. Fertil Steril 1993; 60: 456-60.
18. Haber HP, Ranke MB. Pelvic ultrasonography in Turner syndrome: standards for uterine and ovarian volume. J Ultrasound Med 1999; 18: 271-6.
19. Gondos B, Kogan SJ. Testicular development during puberty. In: Grumbach MM, Sizonenko PC, Aubert MI, eds. Control of the Onset of Puberty. Baltimore: Williams & Wilkins, 1990: 387-402.
20. Nielsen CT, Skakkebaek NE, Richardson DW et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab 1986; 62: 532-5.
21. Janczewski Z, Bablok L. Semen characteristics in pubertal boys. II. Semen quality in relation to bone age. Arch Androl 1985; 15: 207-11.
22. Carlson SE. Gynecomastia. N Engl J Med 1980; 404: 795-9.
23. Bachrach LK, Hastie T, Wang M et al. Bone mineral acquisition in healthy Asian, Hispanic, black and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab 1999; 84: 4702-12.
24. Ferrari S, Rizzoli R, Slosman D, Bonjour JP. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998; 83: 358-61.
25. Barr SI, McKay HA. Nutrition, exercise, and bone status in youth. Int J Sport Nutr 1998; 8: 124-42.
26. Kardinaal AF, Ando S, Charles P et al. Dietary calcium and bone density in adolescent girls and young women in Europe. J Bone Min Res 1999; 14: 583-92.
27. Rico H, Revilla M, Villa LF, Hernandez ER, Alvarez de Buergo M, Villa M. Body composition in children and Tanner's stages: a study with dual-energy x-ray absorptiometry. Metabolism 1993; 42: 967-70.
28. Cheek DB. Body composition, hormones, nutrition and adolescent growth. In: Grumbach MM, Grave GD, Mayer FE, eds. Control of the Onset of Puberty. New York: John Wiley & Sons, 1974: 424-47.
29. Tanner JM, Whitehouse RH, Marubini E, Resele LF. The adolescent growth spurt of boys and girls of the Harpenden growth study. Ann Hum Biol 1976; 3: 109-26.
30. Largo RH, Gasser TH, Prader A. Analysis of the adolescent growth spurt using smoothing spline functions. Ann Hum Biol 1978; 5: 421-34.
31. Martha PM Jr, Rogol AD, Veldhuis JD. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab 1989; 69: 563-70.
32. Veldhuis JD, Metzger DL, Martha PMJ et al. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 1997; 82: 3414-20.
33. Metzger DL, Kerrigan JR. Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence. J Clin Endocrinol Metab 1994; 79: 513-18.
34. Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biologic markers of bone turnover. Endocr Rev 1996; 17: 333-68.
35. Ross JL, Cassorla FG, Skerda MC et al. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med 1984; 309: 1104-6.
36. Grumbach MM, Auchus RJ. Estrogen: consequences and implication of human mutations in synthesis and action. J Clin Endocrinol Metab 1999; 84: 4677-94.
37. Cutler GB. The role of estrogen in bone growth and maturation during childhood and adolescence. J Steroid Biochem Mol Biol 1997; 61: 141-4.
38. Adelman JP, Mason AJ, Hayflick JS et al. Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat. Proc Natl Acad Sci USA 1986; 83: 179-83.
39. Schwanzel-Fukada M, Jorgensen KL, Bergen HT et al. Biology of normal luteinizing hormone-releasing hormone neurons during and after their migration from olfactory placode. Endocr Rev 1992; 13: 623-34.
40. Seminara SB, Hayes FJ, Crowley WFJ. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev 1999; 19: 521-39.
41. Wetsel WC, Valenca MM, Merchenthaler I et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci USA 1992; 89: 4149-53.
42. Mitsushima D, Hei DL, Terasawa E. Gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty. Proc Natl Acad Sci USA 1994; 91: 395-9.
43. Hazum E, Conn PM. Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor. Endocr Rev 1988; 9: 379-86.
44. Huckle W, Conn PM. Molecular mechanisms of gonadotropin releasing hormone action. II. The effector system. Endocr Rev 1988; 9: 387-95.
45. Huhtaniemi I, Jiang M, Nilsson C, Pettersson K. Mutations and polymorphisms in gonadotropin genes. Mol Cell Endocrinol 1999; 151: 89-94.
46. Layman LC. Mutations in human gonadotropin genes and their physiologic significance in puberty and reproduction. Fertil Steril 1999; 71: 201-18.
47. Reiter EO, Kulin HE, Hamwood SM. The absence of positive feedback between estrogen and luteinizing hormone in sexually immature girls. Pediatr Res 1974; 8: 740-5.
48. Filicori M, Butler JP, Crowley WFJ. Neuroendocrine regulation of the corpus luteum in the human. J Clin Invest 1999; 73: 1638-47.
49. Russell DW, Wilson JD. Steroid 5 a hydroxylase; two genes/two enzymes. Annu Rev Med 1994; 63: 25-61.
50. Mahendroo MS, Mendelson CR, Simpson ER. Tissue specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 1993; 268: 19463-70.
51. Lubahn DR, Joseph DR, Sar M et al. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988; 2: 1265-75.
52. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB. Estrogen levels in childhood determined by an ultrasensitive recom-binant cell bioassay. J Clin Invest 1994; 94: 2475-80.
53. Vale W, Bilezikjian LM, Rivier C. Reproductive and other roles of inhibins and activins. In: Knobil E, Neil JD, eds. Physiology of Reproduction, 2nd edn. New York: Raven Press; 1994: 1861-78.
54. Andersson AM, Toppari J, Haavisto AM et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998; 83: 675-81.
55. Hudson PL, Dougas I, Donahoe PK et al. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990; 70: 16-22.
56. Gluckman PD, Grumbach MM, Kaplan SL. The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr Rev 1981; 2: 363-95.
57. Forest MG. Pituitary gonadotropin and sex steroid secretion during the first two years of life. In: Grumbach MM, Sizonenko PC, Aubert AU, eds. Control of the Onset of Puberty. Baltimore: Williams & Wilkins; 1990: 451-78.
58. Conte FA, Grumbach MM, Kaplan SL, Reiter EO. Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty. J Clin Endocrinol Metab 1980; 50: 163-8.
59. Nathwani NC, Hindmarsh PC, Massarano AA, Brook CGD. Gonadotrophin pulsatility in girls with the Turner syndrome: modulation by exogenous sex steroids. Clin Endocrinol 1998; 49: 107-13.
60. Bridges NA, Matthews DR, Hindmarsh PC, Brook CGD. Changes in gonadotrophin secretion during childhood and puberty. J Endocrinol 1994; 141: 169-76.
61. Dunkel L, Alfthan H, Stenman U et al. Gonadal control of pulsatile secretion of luteinizing hormone and follicle-stimulating hormone in prepubertal boys evaluated by ultrasensitive timeresolved immunofluorometric assays. J Clin Endocrinol Metab 1990; 70: 107-14.
62. Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty. J Clin Endocrinol Metab 1999; 84: 29-37.
63. Ankarberg C, Norjavaara E. Diurnal rhythm of testosterone secretion before and throughout puberty in healthy girls: correlation with 17beta-estradiol and dehydroepiandrosterone sulfate. J Clin Endocrinol Metab 1999; 84: 975-84.
64. Farooqi IS, Jebb SA, Langmack G et al. Brief report: effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-84.
65. Ahmed ML, Ong KK, Morrell DJ et al. Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab 1999; 84: 899-905.
66. Arslanian S, Suprasongsin C, Kalhan SC, Drash AL, Brna R, Janosky JE. Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity, and energy expenditure. Metab Clin Exp 1998; 47: 309-12.
67. Grumbach MM, Richards GE, Conte FA et al. Clinical disorders of adrenal function and puberty: an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone. In: James VHT, Serio M, Giusti G et al., eds. The Endocrine Function of the Human Adrenal Cortex, Serono Symposium. New York: Academic Press, 1977: 583-612.
68. Schiebinger RJ, Albertson BD, Cassorla FG et al. The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17, 20-desmolase. J Clin Invest 1981; 67: 1177-82.
69. Bridges NA, Christopher JA, Hindmarsh PC, Brook CGD. Sexual precocity: sex incidence and aetiology. Arch Dis Child 1994; 70: 116-18.
70. Lebrethon MC, Bourguignon JP. Management of central isosexual precocity: diagnosis, treatment and outcome. Curr Opin Pediatr 2000; 12: 394-9.
71. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics 2003; 111: 47-51.
72. Pescovitz OH, Comite F, Hench K et al. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone-releasing hormone analogue therapy. J Paediatr 1986; 108: 47-54.
73. Stanhope R, Brook CGD, Pringle PJ, Adams J, Jacobs HS. Induction of puberty by pulsatile gonadotrophin-releasing hormone. Lancet 1987; ii: 552-5.
74. Donaldson MDC, Stanhope R, Lee TJ, Price DA, Brook CGD, Savage DCL. Gonadotrophin responses to GnRH in precocious puberty treated with GnRH analogue. Clin Endocrinol 1984; 21: 499-503.
75. Ng SM, Kumar Y, Cody D, Smith CS, Didi M. Cranial MRI scans are indicated in all girls with central precocious puberty. Arch Dis Child 2003; 88: 414-18.
76. Junier MP, Wolff A, Hoffman G, Ma YJ, Ojeda SR. Effect of hypothalamic lesions that induce precocious puberty on the morphological and functional maturation of the luteinizing hormone releasing hormone neuronal system. Endocrinology 1992; 131: 787-98.
77. Mahachoklerwattana P, Kaplan SL, Grumbach MM. The luteinizing hormone-releasing hormone-secreting hypothala-mic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 1993; 77: 118-24.
78. Quigley C, Cowell C, Jimenez M et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukaemia. N Engl J Med 1989; 321: 143-51.
79. Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994; 78: 1282-6.
80. Herman ME, Giddens AD, Sandler NE, Freidman NE. Sexual precocity in girls: an association with sexual abuse? Am J Dis Child 1988; 142: 431-3.
81. Dacou-Voutetakis C, Karidis N Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH agonist analogue. Ann NY Acad Sci USA 1993; 687: 250-4.
82. Krstevska-Konstantinova M, Charlier C, Craen M et al. Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. Hum Reprod 2001; 16: 1020-6.
83. Boepple PA, Frisch LS, Wierman HE, Hoffman WH, Crowley WF. The natural history of autonomous gonadal function, adrenarche and central puberty in gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1992; 75: 1550-5.
84. Rosenthal SM, Grumbach MM, Kaplan SL. Gonadotrophin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab 1983; 57: 571-9.
85. Latronico AC, Abell AN, Arnhold IJP et al. A unique con-stitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotrophin-independent precocious puberty. J Clin Endocrinol Metab 1998; 83: 2435-40.
86. Kremer H, Martens JWM, Van Reen M et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab 1999; 84: 1136-40.
87. Iiri T, Herzmark P, Nakamoto JM, van Dop C, Bourne HR. Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function. Nature 1994; 371: 164-8.
88. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome: long-term follow up. JAMA 1986; 256: 2980-4.
89. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Freidman E, Speigel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325: 1688-95.
90. Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB Jr. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotrophin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 1988; 67: 474-9.
91. Stanhope R, Brook CGD. Thelarche variant: a new syndrome of precocious sexual maturation? Acta Endocrinol (Copenh) 1990; 123: 481-6.
92. Beck W, Stubbe P. Pulsatile secretion of luteinizing hormone and sleep-related gonadotrophin rhythms in girls with premature thelarche. Pediatrics 1984; 141: 168-70.
93. Anasti JN, Flack MR, Froehlich J, Nelson LM, Nisula BC. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80: 276-9.
94. Pringle PJ, Stanhope R, Hindmarsh PC, Brook CGD. Abnormal pubertal development in primary hypothyroidism. Clin Endo-crinol 1988; 28: 479-86.
95. Adams DM, Young PC, Copeland KC. Pubic hair in infancy. Am J Dis Child 1992; 146: 149-51.
96. Ibanez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998; 83: 3558-62.
97. Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V. Isolated precocious pubarche: an approach. J Clin Endocrinol Metab 1994; 79: 582-9.
98. Ibanez L, Potau N, Virdis R et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1599-1603.
99. Ehrhardt AA, Meyer-Bahlburg HFL. Psychosocial aspects of precocious puberty. Horm Res 1994; 4 (Suppl. 2): 30-5.
100. Bridges NA, Cooke A, Healy MJR, Hindmarsh PC, Brook CGD. Standards for ovarian volume in childhood and puberty. Fertil Steril 1993; 60: 456-60.
101. Freedman SM, Krietzer PM, Elkowitz SS, Leonidas JC. Ovarian microcysts in girls with isolated premature thelarche. J Pediatr 1993; 122: 246-9.
102. Mauras N, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinol Scand (Suppl.) 1986; 279: 207-17.
103. Honour JW, Price DA, Taylor NF, Marsden HB, Grant DB. Steroid biochemistry of virilising adrenal tumours in childhood. Eur J Pediatr 1984; 142: 165-9.
104. Rosenfeld RL. Selection of children with precocious puberty for treatment with gonadotrophin releasing hormone analogs. J Pediatr 1994; 124: 989-91.
105. Kaplan SL, Grumbach MM. Pathogenesis of sexual precocity. In: Grumbach MM, Sizonenko PC, Aubert ML, eds. Control of the Onset of Puberty. Baltimore: Williams and Wilkins, 1990: 620-62.
106. Thamdrup E. Precocious Sexual Development: a Clinical Study of 100 Children. Springfield: Thomas; 1961: 44-63.
107. Sigurjonsdottir TJ, Hayles AB. Precocious puberty. Am J Dis Child 1968; 115: 309-21.
108. Oerter Klein K. Precocious puberty: who has it? who should be treated? J Clin Endocrinol Metab 1999; 84: 411-13.
109. Sorgo W, Kinaly E, Homoki J et al. The effects of cyproterone acetate on skeletal growth in children with precocious puberty. Acta Endocrinol (Copenh) 1987; 115: 44-56.
110. Conn PM. The molecular basis of gonadotrophin-releasing hormone action. Endocr Rev 1986; 7: 3-10.
111. Conn PM, Crowley WF. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994; 45: 391-405.
112. Merke DP, Cutler GB Jr. Evaluation and management of precocious puberty. Arch Dis Child 1996; 75: 269-71.
113. Kletter GB, Kelch RP. Effects of gonadotrophin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 1994; 79: 331-4.
114. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long-term effect of gonadotrophin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab 1995; 80: 546-51.
115. Galluzzi F, Salti R, Bindi G, Pasquini E, La Cauza C. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy. Acta Paediatr 1998; 87: 521-7.
116. Kauli R, Kornreich L, Laron Z. Pubertal development, growth and final height in girls with sexual precocity treated with the GnRH analogue D-TRP-6-LHRH. Horm Res 1990; 33: 11-17.
117. Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB. Adult height after long term treatment with deslorelin. J Clin Endocrinol Metab 1991; 73: 1235-40.
118. Walvoord EC, Pescovitz OH. Combined use of growth hormone and gonadotrophin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 1999; 104: 1010-14.
119. Werder EA, Murset G, Zachmann M, Brook CGD, Prader A. Treatment of precocious puberty with cyproterone acetate. Pediatr Res 1974; 8: 248-56.
120. Zachmann M, Sobradillo B, Frank M, Frisch H, Prader A. Bayley-Pinneau, Roche Wainer Thissen, and Tanner height predictions in normal children and in patients with various pathological conditions. J Pediatr 1978; 93: 749-55.
121. Bar A, Linder B, Sobel EH, Saenger P, Di Martino Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 1995; 126: 955-8.
122. Saggese G, Bertelloni S, Baroncelli GI, Battini R, Franchi G. Reduction in bone density: an effect of gonadotrophin releasing hormone treatment in central precocious puberty. Fertil Steril 1993; 152: 717-20.
123. Boot AM, De Muinck Keizer-Schrama SMPF, Pols HAP, Krenning EP, Drop SLS. Bone mineral density and body composition before and during treatment with gonadotrophin-releasing hormone agonist in children with central precocious and early puberty. J Clin Endocrinol Metab 1998; 83: 370-3.
124. Feuillan PP, Jones J, Cutler GB. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 1993; 77: 647-51.
125. Laue L, Kenigsberg D, Pescovitz OH et al. Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med 1989; 320: 496-502.
126. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 1987; 317: 812-18.
127. Jay N, Mansfield MJ, Blizzard RM et al. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotrophin releasing hormone agonists. J Clin Endocrinol Metab 1992; 75: 890-4.
128. Cisternino M, Pasquino A, Bozzola M et al. Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate. Horm Res 1992; 37: 86-90.
129. Boepple PA, Frisch LS, Weirman ME, Hoffman WH, Crowley WF. The natural history of autonomous gonadal function, adrenarche and central puberty in gonadotrophin independent precocious puberty. J Clin Endocrinol Metab 1992; 75: 1550-5.
130. Merkus PJ, van Essen Zandvliet EE, Duiverman EJ, van Houwelingen HC, Kerrebijn KF, Quanjer PH. Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993; 91: 1121-6.
131. Patel L, Clayton PE, Addison GM, Price DA, David TJ. Linear growth in prepubertal children with atopic dermatitis. Arch Dis Child 1998; 79: 169-72.
132. Johanesson M, Gottleib C, Hjelte L. Delayed puberty in girls with cystic fibrosis despite good clinical status. Pediatrics 1997; 99: 29-34.
133. Brain CE, Savage MO. Growth and puberty in chronic inflammatory bowel disease. Bailliere's Clin Gastroenterol 1994; 8: 83-100.
134. Lanes R, Gunczler P, Osuna JA. Effectiveness and limitations of the use of the gonadotropin-releasing hormone agonist leuprolide acetate in the diagnosis of delayed puberty in males. Horm Res 1997; 48: 1-4.
135. Ghai K, Cara KF, Rosenfield RL. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys-a clinical research center study. J Clin Endocrinol Metab 1995; 80: 2980-6.
136. Houchin LD, Rogol AD. Androgen replacement in children with constitutional delay of puberty: the case for aggressive therapy. Bailliere's Clin Endocrinol Metab 1998; 12: 427-40.
137. Saenger P, Sandberg DE. Delayed puberty: when to wake the bugler. J Pediatr 1998; 13: 724-6.
138. Buyukgebiz A, Hindmarsh PC, Brook CGD. Treatment of constitutional growth and puberty with oxandrolane compared with growth hormone. Arch Dis Child 1990; 65: 448-52.
139. Arrigo T, Cisternino M, Luca De F et al. Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty. J Pediatr Endocrinol Metab 1996; 9: 511-17.
140. Dattani MT, Robinson ICAF. The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 2000; 57: 337-46.
141. Rugliari EI, Ballabio A. Kallman syndrome: from genetics to neurobiology. JAMA 1993; 270: 2713-16.
142. Reutens AT, Achermann JC, Ito M et al. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J Clin Endocrinol Metab 1999; 84: 504-11.
143. Hernandez Martin A, Gonzalez Sarmiento R, De-Unamuno P. X-linked ichthyosis: an update. Br J Dermatol 1999; 141: 617-27.
144. Semibara SB, Messager S, Chatzidaki EE et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349: 1614-27.
145. Oerter KE, Kamp GA, Munson PJ, Nienhaus AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 1993; 76: 357-61.
146. Hindmarsh PC, Brook CGD. Principles underlying endocrine tests. In: Brook CGD and Hindmarsh PC, eds. Clinical Paediatric Endocrinology, 4th edn. Oxford: Blackwell Science, 2001: 45.
147. Dunkel L, Perheentupa J, Virtanen M, Maenpaa J. Gonadotropin-releasing hormone test and human chorionic gonadotropin test in the diagnosis of gonadotropin deficiency in prepubertal boys. J Pediatr 1985; 107: 388-92.
148. Bouloux PM, Handelsman DJ, Jockenhovel F et al. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod 2001; 16: 1592-7.
149. Smals AG, Hermus AR, Boers GH, Pieters GF, Benraad TJ, Kloppenborg PW. Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypo-gonadotropic hypogonadism. J Clin Endocrinol Metab 1994; 78: 602-8.
150. Bakker B, Massa GG, Oostdijk W, Van Weel-Sipman MH, Vossen JM, Wit JM. Pubertal development and growth after total-body irradiation and bone marrow transplantation for hematological malignancies. Eur J Pediatr 2000; 159: 31-7.
151. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107-34.
152. Fraser IS, Russell P, Greco S, Robertson DM. Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Clin Reprod Fertil 1986; 4: 133-8.
153. Brook CGD, Gasser T, Werder EA, Prader A, Vanderschueren-Lodewykx MA. Height correlations between parents and mature offspring in normal subjects and in subjects with Turner's and Klinefelter's and other syndromes. Ann Hum Biol 1977; 4: 17-22.
154. Smyth CM, Bremner WJ. Klinefelter syndrome. Arch Intern Med 1998; 158: 1309-14.
155. Davies MC. Management of infertility and the newer reproductive techniques: treatment opportunities and ethical implications. In: Stanhope R, ed. Adolescent Endocrinology. Bristol: BioScientifica, 1998: 59-67.
156. Stanhope R, Brook CGD, Pringle PJ, Adams J, Jacobs HS. Induction of puberty by pulsatile GnRH. Lancet 1987; 2: 522-5.
157. Meachem SJ, McLachlan RI, de Kretser DM, Robertson DM, Wreford NG. Neonatal exposure of rats to recombinant follicle stimulating hormone increases adult Sertoli and spermatogenic cell numbers. Biol Reprod 1996; 54: 36-44.
158. Crowne EC, Shalet SM, Wallace WHB, Eminson DM, Price DA. Final height in girls with untreated constitutional delay of puberty. Eur J Pediatr 1991; 150: 708-12.
159. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with history of delayed puberty. N Engl J Med 1992; 326: 600-4.
160. Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab 1996; 81: 1152-5.
161. Bertelloni S, Baroncelli GI, Ferdeghini M, Perri G, Saggesse G. Normal volumetric and bone mineral density and bone turnover in young men with histories of constitutional delay of puberty. J Clin Endocrinol Metab 1998; 83: 4280-3.